Permission to prescribe: do cardiologists need permission to prescribe diabetes medications that afford cardiovascular benefit?-Reference-Cited by-同舟云学术

Permission to prescribe: do cardiologists need permission to prescribe diabetes medications that afford cardiovascular benefit?

Published:2021-06-25 Issue:5 Volume:36 Page:672-681
ISSN:0268-4705
Container-title:Current Opinion in Cardiology
language:en
Short-container-title:

Author:

Sharma Abhinav,Aziz Haya,Verma Subodh,Abramson Beth L.,Choi Richard,Chua Grace L.,Connelly Kim A.,Honos George,Mancini G.B. John,Ramer Sarah A.,Swiggum Elizabeth,Teoh Hwee,Zieroth Shelley,Leiter Lawrence A.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference57 articles.

1. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017;Einarson;Cardiovasc Diabetol,2018

2. Trends in noncardiovascular comorbidities among patients hospitalized for heart failure: insights from the get with the guidelines-heart failure registry;Sharma;Circ Heart Fail,2018

3. Causes of death in a contemporary cohort of patients with type 2 diabetes and atherosclerotic cardiovascular disease: insights from the TECOS trial;Sharma;Diabetes Care,2017

4. Effects of intensive glucose lowering in type 2 diabetes;Gerstein;N Engl J Med,2008

5. Intensive glucose control and macrovascular outcomes in type 2 diabetes;Turnbull;Diabetologia,2009

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utilizing synchronous care to improve cardiovascular and renal health among patients with type 2 diabetes: Proof‐of‐concept results from the DECIDE‐CV clinical programme;Diabetes, Obesity and Metabolism;2024-06-03

2. Primary and Secondary Cardiovascular and Kidney Prevention With Canagliflozin: Insights From the CANVAS Program and CREDENCE Trial;Journal of the American Heart Association;2024-02-06

3. Emerging Medical Therapies for the Treatment of Obesity in Women with Cardiovascular Diseases;Current Cardiology Reports;2023-10-24

4. Effect of Sotagliflozin on Early Mortality and Heart Failure-Related Events;JACC: Heart Failure;2023-08

5. GLP-1 Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes;Circulation;2022-12-13